by The Mount Sinai Hospital Credit: Pixabay/CC0 Public Domain Mount Sinai scientists have developed a new technology allowing them to link specific genes to complex tumor characteristics at a scale and resolution not previously possible. The results could lead to new approaches for targeting anti-cancer drugs. The technology, called Perturb-map, uses a novel genetic barcode...
